Europe Thyroid Ablation Devices Market is expected to grow with the CAGR of 9.7% in the forecast period of 2021 to 2028. The years considered for study are as mentioned below:
Access Full Report @ https://www.databridgemarketresearch.com/ar/reports/europe-thyroid-ablation-devices-market
Europe thyroid ablation devices market is a highly consolidated market which includes specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenario.
The major players dealing in Europe thyroid ablation devices market are introducing strong range of products provider along with launching new products and adopting strategic initiative such as acquisition, agreement into the market. This has helped the companies to maximize the sales with enhanced product portfolio. For instance, in October 2020, Olympus Corporation had collaborated with CYBERNET SYSTEMS, CO, LTD to establish an AI diagnostic support system at a major medical institution, the Asian Institute of Gastroenterology (AIG) based in Hyderabad, India. The initiative by the company would ensure that the lecturers from Showa University Northern Yokohama Hospital deliver expert guidance to AIG doctors. It would deliver a positive growth in the market.
Terumo Europe NV (a subsidiary of Terumo Corporation) is the dominating player in Europe thyroid ablation devices market. The other key players existing in the thyroid ablation devices market includes Smith & Nephew, CONMED Corporation, Koninklijke Philips N.V., BIOTRONIK SE & Co. KG, Imricor, Stryker, Lepu Medical Technology(Beijing)Co.,Ltd., Trod Medical, Baylis Medical Company, Inc, Integra LifeSciences Corporation, Merit Medical Systems, Carl Zeiss Meditec AG, IceCure Medical, Theraclion, Chongqing Haifu Medical Technology Co., Ltd., Sonacare Medical, Mechan Europe Ltd, DirexGroup, Boston Scientific Corporation, AngioDynamics, Medtronic, Olympus Corporation, AtriCure, Inc., Biosense Webster, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) among others.
Terumo Europe NV (a subsidiary of Terumo Corporation):
Terumo Europe NV (a subsidiary of Terumo Corporation) is headquartered in Leuven, Belgium and was founded in 1971. The company is focused in providing the best in class quality products and services through innovative and sustainable growth. The company provides products under categories such as ablation systems, accessories, catheters, closure devices, coils, electromechanical products, filters, guidewire, imaging, microspheres, monitoring systems, needles & syringes, perfusion products, safety devices, sheaths stents and surgical products among which ablation systems is the market focused category.
For instance,
- In July 2019, Terumo Europe NV (a subsidiary of Terumo Corporation) announced that they had invested Euro 26.00 million to develop a new manufacturing facility in Belgium. This is because of the growing demand for the product and its revenue in the forecasted period from the European region.
The company has wide presence across Europe and Middle East and Africa.
Biosense Webster, Inc. (a subsidiary of Johnson & Johnson Services, Inc.):
Biosense Webster, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) is headquartered in California, U.S. and was founded in 1970. The company is the global leader in the science of diagnosing and treating heart rhythm disorders. The company deals in multiple business segments such as consumer health, pharmaceutical and medical devices among which medical devices is the market focused segment. The company provides products under categories such as access, adjunctive hemostats, CMF, early intervention, energy sealing & dissecting, foot & ankle, hernia mesh & fixation, hip joint reconstruction knee, ligation, magnetic sphincter augmentation, microwave ablation, Mitek sports medicine, other endoscopic instruments, power tools, shoulder, spine, surgical stapling, trauma and extremities, trauma – pediatrics, uterine & pelvic, vascular access & infection control and wound closure among which microwave ablation is the market focused category.
For instance,
- In May 2020, BioSense Webster, Inc. had confirmed the product trial results of THERMOCOOL SMARTTOUCH SF Ablation Catheter used for the treatment of persistent atrial fibrillation (AF). The data was collected from the PRECEPT study data. The result delivered would result in awareness among surgeons about the minimal invasive treatment for atrial fibrillation. It would deliver a positive growth in the market.
The company has wide presence across Asia-Pacific, Europe, Middle East and Africa, South America and North America.
Smith & Nephew:
Smith & Nephew is headquartered in Hertfordshire, U.K. and was founded in 1856. The company engages in the development, manufacture, marketing and sale of medical devices. The company deals in multiple business segments such as advanced wound management, orthopedics & trauma and sports medicine & ENT among which sports medicine & ENT is the market focused segment. The company provides products under categories such as wound care products, wound therapy areas, dressing types, orthopaedic reconstruction, real intelligence, sports medicine, trauma & extremities and ENT among which ENT and sports medicine are the market focused categories.
For instance,
- In September 2020, Smith & Nephew announced that they have signed a partnership to pilot its innovative Bump social-distancing system with Tharus, a robotic company. Under this, Tharus will upgrade the manufacturing process of the company which will help to maintain social distancing and to bring people to work. This will help the company to meet the global demand of products.
The company has wide presence across North America, South America, Europe, Asia-Pacific and Middle East and Africa. The company has various subsidiary companies such as Smith & Nephew Argentina S.R.L.2 (Argentina), Smith & Nephew Pty Limited (Australia), Smith & Nephew Medical (Shanghai) Limited (China), Smith & Nephew S.A. de C.V. (Mexico), Smith & Nephew Limited (New Zealand) among others.
